KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Times Interest Earned: 2017-2024

Historic Times Interest Earned for Aquestive Therapeutics (AQST) over the last 8 years, with Dec 2024 value amounting to -$2.77.

  • Aquestive Therapeutics' Times Interest Earned fell 38.52% to -$4.13 in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.02, marking a year-over-year decrease of 152.37%. This contributed to the annual value of -$2.77 for FY2024, which is 16.09% down from last year.
  • Aquestive Therapeutics' Times Interest Earned amounted to -$2.77 in FY2024, which was down 16.09% from -$2.38 recorded in FY2023.
  • In the past 5 years, Aquestive Therapeutics' Times Interest Earned registered a high of -$2.38 during FY2023, and its lowest value of -$6.42 during FY2022.
  • Moreover, its 3-year median value for Times Interest Earned was -$2.77 (2024), whereas its average is -$3.86.
  • In the last 5 years, Aquestive Therapeutics' Times Interest Earned crashed by 86.04% in 2022 and then surged by 62.88% in 2023.
  • Aquestive Therapeutics' Times Interest Earned (Yearly) stood at -$3.88 in 2020, then rose by 10.98% to -$3.45 in 2021, then tumbled by 86.04% to -$6.42 in 2022, then soared by 62.88% to -$2.38 in 2023, then decreased by 16.09% to -$2.77 in 2024.